Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitors

被引:50
|
作者
O'Meara, Jeff A. [1 ]
Jakalian, Araz [1 ]
LaPlante, Steven [1 ]
Bonneau, Pierre R. [1 ]
Coulombe, Rene [1 ]
Faucher, Anne-Marie [1 ]
Guse, Ingrid [1 ]
Landry, Serge [1 ]
Racine, Jennifer [1 ]
Simoneau, Bruno [1 ]
Thavonekham, Bounkham [1 ]
Yoakim, Christiane [1 ]
机构
[1] Boehringer Ingelheim Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada
关键词
NNRTI; scaffold hopping; tertiary amide; tertiary carbamate; thio-tetrazole; tetrazole thioacetanilide;
D O I
10.1016/j.bmcl.2007.03.097
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
High-throughput screening hit 1 was identified as a potent, broad-spectrum, non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1 replication. Analysis of the bound conformation of analogs of this inhibitor via molecular modeling and NMR contributed to the design of novel tertiary amide, carbamate, and thiocarbamate based NNRTIs. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3362 / 3366
页数:5
相关论文
共 50 条
  • [1] Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
    Chong, Pek
    Sebahar, Paul
    Youngman, Michael
    Garrido, Dulce
    Zhang, Huichang
    Stewart, Eugene L.
    Nolte, Robert T.
    Wang, Liping
    Ferris, Robert G.
    Edelstein, Mark
    Weaver, Kurt
    Mathis, Amanda
    Peat, Andrew
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (23) : 10601 - 10609
  • [2] Searching for novel scaffold of triazole non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Fraczek, Tomasz
    Paneth, Agata
    Kaminski, Rafal
    Krakowiak, Agnieszka
    Paneth, Piotr
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (03) : 481 - 489
  • [3] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [4] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [5] Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1
    Chan, JH
    Freeman, GA
    Tidwell, JH
    Romines, KR
    Schaller, LT
    Cowan, JR
    Gonzales, SS
    Lowell, GS
    Andrews, CW
    Reynolds, DJ
    St Clair, M
    Hazen, RJ
    Ferris, RG
    Creech, KL
    Roberts, GB
    Short, SA
    Weaver, K
    Koszalka, GW
    Boone, LR
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) : 1175 - 1182
  • [6] QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Duchowicz, Pablo R.
    Fernandez, Michael
    Caballero, Julio
    Castro, Eduardo A.
    Fernandez, Francisco M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 5876 - 5889
  • [7] Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1
    Moreno, S
    Casado, JL
    Pérez-Elias, MI
    Dronda, F
    Antela, A
    Moreno, A
    Gutiérrez, C
    AIDS, 2003, 17 (09) : 1413 - 1414
  • [8] Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors: A Combinatorial Approach
    Valuev-Elliston, V. T.
    Kochetkov, S. N.
    BIOCHEMISTRY-MOSCOW, 2017, 82 (13) : 1716 - 1743
  • [9] Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors
    Murugesan, Vanangamudi
    Makwana, Nandini
    Suryawanshi, Rahul
    Saxena, Reshu
    Tripathi, Rajkamal
    Paranjape, Ramesh
    Kulkarni, Smita
    Katti, Seturam B.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (12) : 3159 - 3170
  • [10] Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: A combinatorial approach
    V. T. Valuev-Elliston
    S. N. Kochetkov
    Biochemistry (Moscow), 2017, 82 : 1716 - 1743